Formulation Design Principles
The Breastomil portfolio is engineered to address key clinical challenges in pediatric gastrointestinal tolerance, metabolic absorption, and accelerated neonatal catch-up growth.
Whey-Predominant Protein Matrix
Breastomil Premium Stage 1 incorporates a 60:40 whey-to-casein ratio. Whey remains liquid in gastric acid, promoting faster gastric emptying, reducing regurgitation, and minimizing stool hardness compared to casein-heavy formulas.
MCT Lipid Assimilation in LBW
Breastomil Pre-Term integrates ~30% Medium Chain Triglycerides (MCTs). MCTs do not require bile acid emulsification or pancreatic lipase for absorption, providing immediate, non-stressful energy for premature infants.
Maltodextrin Digestive Rest
In acute gastrointestinal inflammation or secondary lactase enzyme deficiency, Breastomil Lactose Free replaces disaccharides with low-osmolarity maltodextrin, preventing osmotic diarrhea and aiding intestinal mucosal recovery.
Physician Sample & Monograph Request
Registered medical practitioners and hospital procurement leads may request evaluation samples and detailed nutritional dossiers below.
Clinical & Technical Questions
Answers to common clinician inquiries regarding formulation standards and availability.